Skip to content

A DOUBLE BLIND RANDOMIZED CONTROL TRIAL TO COMPARE POSTOPERATIVE ANALGESIA WITH EPIDURAL BUPIVACAINE 0.25% AND ROPIVACAINE 0.2%

A DOUBLE BLIND RANDOMIZED CONTROL TRIAL TO COMPARE POSTOPERATIVE ANALGESIA WITH EPIDURAL BUPIVACAINE 0.25% AND ROPIVACAINE 0.2%

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049743
Enrollment
80
Registered
2023-02-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Control Intervention1: BUPIVACAINE 0.25% INFUSION VIA EPIDURAL CATHETER: Every patient posted for Lumbar spine surgery will be selected based on selection criteria and randomly divided into two group

Sponsors

Bharati hospital and Research centre
Lead Sponsor
Bharati hospital and Research centre
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1)American Society of Anaesthesiologists (ASA) Grade I & II patients,of both sexes. 2)Patients undergoing Lumbar spine surgery under GA 3)Patients in the age group of above 18years

Exclusion criteria

Exclusion criteria: 1)Individuals not willing to participate in the study 2)any previous local anesthetic or opioid allergy 3)a history of previous spine surgery, 4) Individuals with sensory and motor deficits

Design outcomes

Primary

MeasureTime frame
TO COMPARE EPIDURAL 0.25% BUPIVACAINE AND 0.2% ROPIVACAINE FOR POST OPERATIVE ANALGESIA IN SPINE SURGERYTimepoint: post operative 48 hours

Secondary

MeasureTime frame
1)To compare VAS score between two groups. 2)To compare Bromage scale under the effect of Bupivacaine and Ropivacaine. 3)To compare the time to perform the specific maneuvers between two groupsTimepoint: post operative 48 hours

Countries

India

Contacts

Public ContactDR VENISHETTY RAJESH

BHARATI VIDYAPEETH DEEMED TO BE UNIVERSITY MEDICAL COLLEGE

varshkeniya@yahoo.com9881419089

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026